Kvβ1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels

Anesthesiology

Volumn 107, Issue 4, 2007, Pages 641-651

  Arias, Cristina ^a,c   Guizy, Miriam ^a,c   David, Miren ^a,c   Marzian, Stefanie ^b   González, Teresa ^a,c   Decher, Niels ^b   Valenzuela, Carmen ^a,c  

^a Instituto Nacional de Toxicologia   (Spain)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.5; KCNAB1 PROTEIN, HUMAN; LOCAL ANESTHETIC AGENT; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; ENANTIOMER; HUMAN; HUMAN CELL; IC 50; MEMBRANE POTENTIAL; NONHUMAN; OOCYTE; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; STEREOCHEMISTRY; VOLTAGE CLAMP; WHOLE CELL; XENOPUS; ALGORITHM; ANIMAL; CELL LINE; CHEMISTRY; ELECTROPHYSIOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; STEREOISOMERISM; XENOPUS LAEVIS;

ALGORITHMS; ANESTHETICS, LOCAL; ANIMALS; BINDING SITES; BUPIVACAINE; CELL LINE; ELECTROPHYSIOLOGY; HUMANS; KV1.3 POTASSIUM CHANNEL; KV1.5 POTASSIUM CHANNEL; MUTATION; OOCYTES; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; STEREOISOMERISM; TRANSFECTION; XENOPUS LAEVIS;

EID: 34748858527     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000282100.32923.5c     Document Type: Article

References (54)

1. Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E: Pharmacology of cardiac potassium channels. Cardiovasc Res 2004; 62:9-33
2. Nerbonne JM, Kass RS: Molecular physiology of cardiac repolarization. Physiol Rev 2005; 85:1205-53
3. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268:C799-822
4. Jackson WF: Potassium channels in the peripheral microcirculation. Microcirculation 2005; 12:113-27
5. + channel from vascular and visceral smooth muscles. Am J Physiol 1994; 267:C1231-8
6. + channel protein in explanted cardiac tissue. J Clin Invest 1995; 96:282-92
7. + currents in nonfailing human hearts: Similarities between right septal subendocardial and left subepicardial ventricular myocytes. Circulation 1995; 92:1179-87
8. + current in human atrial myocytes. Circ Res 1996; 78:903-15
9. + channel cDNAs from human ventricle. FASEB J 1991; 5:331-7
10. Snyders DJ, Tamkun MM, Bennett PB: A rapidly activating and slowly inactivating potassium channel cloned from human heart: Functional analysis after stable mammalian cell culture expression. J Gen Physiol 1993; 101:513-43
11. + current similar to Kv1.5 cloned channel currents. Circ Res 1993; 73:1061-76
12. Deal KK, England SK, Tamkun MM: Molecular physiology of cardiac potassium channels. Physiol Rev 1996; 76:49-76
13. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997; 80:772-81
14. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A: Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006; 15:2185-91
15. Weir EK, Lopez-Barneo J, Buckler KJ, Archer SL: Acute oxygen-sensing mechanisms. N Engl J Med 2005; 353:2042-55
16. + channel β subunit expressed in human heart. Proc Natl Acad Sci U S A 1995; 92:6309-13
17. Uebele VN, England SK, Chaudhary A, Tamkun MM, Snyders DJ: Functional differences in Kv1.5 currents expressed in mammalian cell lines are due to the presence of endogenous Kvβ2.1 subunits. J Biol Chem 1996; 271:2406-12
18. Decher N, Kumar P, Gonzalez T, Renigunta V, Sanguinetti MC: Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels. Mol Pharmacol 2005; 68:995-1005
19. Gonzalez T, Navarro-Polanco R, Arias C, Caballero R, Moreno I, Delpon E, Tamargo J, Tamkun MM, Valenzuela C: Assembly with the Kvβ1.3 subunit modulates drug block of hKv1.5 channels. Mol Pharmacol 2002; 62:1456-63
20. Strichartz GR, Ritchie JM: The action of local anesthetics on ion channels of excitable tissues, Local Anesthetics. Edited by Strichartz GR. Berlin, Springer Verlag, 1987, pp 21-52
21. Kotelko DM, Shnider SM, Dailey PA, Brizgys RV, Levinson G, Shapiro WA, Koike M, Rosen MA: Bupivacaine-induced cardiac arrhythmias in sheep. ANESTHESIOLOGY 1984; 60:10-8
22. Clarkson CW, Hondeghem LM: Mechanism for bupivacaine depression of cardiac conduction: Fast block of sodium channels during the action potential with slow recovery from block during diastole. ANESTHESIOLOGY 1985; 62:396-405
23. Sanchez-Chapula J: Effects of bupivacaine on membrane currents of guinea-pig ventricular myocytes. Eur J Pharmacol 1988; 156:303-8
24. Wheeler DM, Bradley EL, Woods WT: The electrophysiologic actions of lidocaine and bupivacaine in the isolated, perfused canine heart. ANESTHESIOLOGY 1988; 68:201-12
25. Solomon D, Bunegin L, Albin M: The effect of magnesium sulfate administration on cerebral and cardiac toxicity of bupivacaine in dogs. ANESTHESIOLOGY 1990; 72:341-6
26. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R: Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69:563-9
27. Lipka LJ, Jiang M, Tseng GN: Differential effects of bupivacaine on cardiac K channels: Role of channel inactivation and subunit composition in drugchannel interaction. J Cardiovasc Electrophysiol 1998; 9:727-42
28. Valenzuela C, Delpon E, Tamkun MM, Tamargo J, Snyders DJ: Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. Biophys J 1995; 69:418-27
29. Gonzalez T, Arias C, Caballero R, Moreno I, Delpon E, Tamargo J, Valenzuela C: Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: Stereoselective bupivacaine block. Br J Pharmacol 2002; 137:1269-79
30. Friederich P, Solth A, Schillemeit S, Isbrandt D: Local anaesthetic sensitivities of cloned HERG channels from human heart: Comparison with HERG/MiRP1 and HERG/MiRP1 T8A. Br J Anaesth 2004; 92:93-101
31. Siebrands CC, Schmitt N, Friederich P: Local anesthetic interaction with human ether-a-go-go-related gene (HERG) channels: Role of aromatic amino acids Y652 and F656. ANESTHESIOLOGY 2005; 103:102-12
32. Luduena F, Bogado E, Tullar B: Optical isomers of mepivacaine and bupivacaine. Arch Int Pharmacodyn Ther 1972; 200:359-69
33. Aberg G: Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol (Copenh) 1972; 31:273-86
34. Valenzuela C, Snyders DJ, Bennett PB, Tamargo J, Hondeghem LM: Stereo-selective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation 1995; 92:3014-24
35. Nau C, Wang SY, Strichartz GR, Wang GK: Block of human heart hH1 sodium channels by the enantiomers of bupivacaine. ANESTHESIOLOGY 2000; 93:1022-33
36. Franqueza L, Longobardo M, Vicente J, Delpon E, Tamkun MM, Tamargo J, Snyders DJ, Valenzuela C: Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ Res 1997; 81:1053-64
37. + channel: Role of S6 in antiarrhythmic drug binding. Circ Res 1996; 78:1105-14
38. Caballero R, Moreno I, Gonzalez T, Valenzuela C, Tamargo J, Delpon E: Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5). Cardiovasc Res 2002; 56:104-17
39. Zhou M, Morais-Cabral JH, Mann S, MacKinnon R: Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 2001; 411:657-61
40. Arias C, David M, Guizy M, Valenzuela C: Kvβ1.3 reduces the degree of stereoselective bupivacaine block of Kvα1.5 channels (abstract). Biophys J 2006; 397a
41. + channel function by the Kvβ1.3 subunit. J Biol Chem 1999; 274:25355-61
42. + channel Kvβ1.3 β-subunit affect voltage-dependent gating. Am J Physiol 1998; 274:C1485-95
43. + channels. J Pharmacol Exp Ther 2001; 296:573-83
44. + channels. J Biol Chem 2004; 279:394-400
45. Armstrong CM: Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J Gen Physiol 1971; 58:413-37
46. Snyders DJ, Knoth KM, Roberds SL, Tamkun MM: Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol 1992; 41:322-30
47. Heinemann SH, Rettig J, Graack HR, Pongs O: Functional characterization of Kv channel beta-subunits from rat brain. J Physiol (Lond) 1996; 493:625-33
48. Friederich P, Solth A: Interaction of ropivacaine with cloned cardiac Kv4.3/KChIP2.2 complexes. ANESTHESIOLOGY 2004; 101:1347-56
49. Solth A, Siebrands CC, Friederich P: Inhibition of Kv4.3/KChIP2.2 channels by bupivacaine and its modulation by the pore mutation Kv4.3V401I. ANESTHESIOLOGY 2005; 103:796-804
50. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, Rhodes KJ: Modulation of A-type potassium channels by a family of calcium sensors. Nature 2000; 403:553-6
51. V channel α- and β-subunits in the bovine pulmonary arterial circulation. Am J Physiol 2001; 281:L1350-60
52. Decher N, Kumar P, Gonzalez T, Pirard B, Sanguinetti MC: Binding site of a novel Kv1.5 blocker: A "foot in the door" against atrial fibrillation. Mol Pharmacol 2006; 70:1204-11
53. Wang Z, Kiehn J, Yang Q, Brown AM, Wible BA: Comparison of binding and block produced by alternatively spliced Kvbeta1 subunits. J Biol Chem 1996; 271:28311-7
54. + channels in mouse ventricular myocytes. Circ Res 2005; 96:451-8